Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HLA-G high-expressor 3'UTR markers are linked to gastric cancer development and survival.
Vaquero-Yuste C, Juarez I, Molina-Alejandre M, Molanes-López EM, Gutiérrez-Calvo A, López-García A, Lasa I, Gómez R, Arnaiz-Villena A, Martín-Villa JM. Vaquero-Yuste C, et al. Among authors: molina alejandre m. Cancer Immunol Immunother. 2024 Nov 16;74(1):26. doi: 10.1007/s00262-024-03771-w. Cancer Immunol Immunother. 2024. PMID: 39549048 Free PMC article.
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer.
Molina-Alejandre M, Perea F, Calvo V, Martinez-Toledo C, Nadal E, Sierra-Rodero B, Casarrubios M, Casal-Rubio J, Martinez-Martí A, Insa A, Massuti B, Viteri S, Barneto Aranda I, Rodriguez-Abreu D, de Castro J, Martínez JM, Cobo M, Wistuba II, Parra ER, Martín-López J, Megías D, Muñoz-Viana R, Garrido F, Aptsiauri N, Ruiz-Cabello F, Provencio M, Cruz-Bermúdez A. Molina-Alejandre M, et al. J Immunother Cancer. 2024 Oct 20;12(10):e009762. doi: 10.1136/jitc-2024-009762. J Immunother Cancer. 2024. PMID: 39428126 Free PMC article.
Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial.
Provencio M, Nadal E, Insa A, García Campelo R, Casal J, Dómine M, Massuti B, Majem M, Rodríguez-Abreu D, Martínez-Martí A, de Castro J, Gómez de Antonio D, Macia I, Figueroa S, Fernández Vago L, Calvo V, Palmero R, Sierra-Rodero B, Martínez-Toledo C, Molina-Alejandre M, Serna-Blasco R, Romero A, Cruz-Bermúdez A. Provencio M, et al. Among authors: molina alejandre m. Lancet Oncol. 2024 Nov;25(11):1453-1464. doi: 10.1016/S1470-2045(24)00498-4. Epub 2024 Oct 14. Lancet Oncol. 2024. PMID: 39419061 Free PMC article. Clinical Trial.
Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer.
Aguinaga-Barrilero A, Juarez I, Vaquero-Yuste C, Molina-Alejandre M, Gutiérrez-Calvo A, Lasa I, López A, Gómez R, Molanes-López EM, Martin-Villa JM. Aguinaga-Barrilero A, et al. Among authors: molina alejandre m. Cell Immunol. 2022 Dec;382:104635. doi: 10.1016/j.cellimm.2022.104635. Epub 2022 Oct 28. Cell Immunol. 2022. PMID: 36332356 Free article.
Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes.
Arnaiz-Villena A, Suarez-Trujillo F, Juarez I, Rodríguez-Sainz C, Palacio-Gruber J, Vaquero-Yuste C, Molina-Alejandre M, Fernández-Cruz E, Martin-Villa JM. Arnaiz-Villena A, et al. Among authors: molina alejandre m. Cell Mol Life Sci. 2022 Aug 4;79(8):464. doi: 10.1007/s00018-022-04491-z. Cell Mol Life Sci. 2022. PMID: 35925520 Free PMC article. Review.
HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.
Martín-Villa JM, Vaquero-Yuste C, Molina-Alejandre M, Juarez I, Suárez-Trujillo F, López-Nares A, Palacio-Gruber J, Barrera-Gutiérrez L, Fernández-Cruz E, Rodríguez-Sainz C, Arnaiz-Villena A. Martín-Villa JM, et al. Among authors: molina alejandre m. Front Immunol. 2022 Jan 27;13:796054. doi: 10.3389/fimmu.2022.796054. eCollection 2022. Front Immunol. 2022. PMID: 35154112 Free PMC article. Review.
HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients.
Vaquero-Yuste C, Juarez I, Molina-Alejandre M, Molanes-López EM, López-Nares A, Suárez-Trujillo F, Gutiérrez-Calvo A, López-García A, Lasa I, Gómez R, Fernández-Cruz E, Rodrígez-Sainz C, Arnaiz-Villena A, Martín-Villa JM. Vaquero-Yuste C, et al. Among authors: molina alejandre m. Front Immunol. 2021 Sep 7;12:698438. doi: 10.3389/fimmu.2021.698438. eCollection 2021. Front Immunol. 2021. PMID: 34557189 Free PMC article.